18 Nov 2024
// PR NEWSWIRE
30 Oct 2024
// PRESS RELEASE
29 Oct 2024
// PR NEWSWIRE
Latest Content by PharmaCompass
01 2ACITRETIN
02 3ASENAPINE MALEATE
03 2ASPIRIN; BUTALBITAL; CAFFEINE
04 1ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
05 2Atropine
06 1BEZAFIBRATE
07 2BRIMONIDINE TARTRATE
08 9Bimatoprost
09 1Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride
10 3Brimonidine Tartrate
11 2CHLORAMPHENICOL
12 1CHLORAMPHENICOL; PREDNISOLONE
13 1CROMOLYN SODIUM
14 1CYCLOSPORINE
15 1Clostridium botulinum neurotoxin typ A
16 3Clostridium botulinum neurotoxin type A
17 1Cyclopentolate
18 1DEXAMETHASONE
19 2DICYCLOMINE HYDROCHLORIDE
20 3DILTIAZEM HYDROCHLORIDE
21 1DIPIVEFRIN HYDROCHLORIDE
22 4DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
23 1Deoxycholic Acid
24 4Dexamethasone
25 1EPINASTINE HYDROCHLORIDE
26 1ESTRADIOL
27 4ETHINYL ESTRADIOL; NORETHINDRONE
28 1ETHOXZOLAMIDE
29 1Epinastine
30 1FERRIC OXYHYDROXIDE
31 4FLUOCINOLONE ACETONIDE
32 1FLUOROMETHOLONE
33 1FLUOROMETHOLONE; SULFACETAMIDE SODIUM
34 1FLURBIPROFEN SODIUM
35 1Flurbiprofen
36 1GATIFLOXACIN
37 1GENTAMICIN SULFATE
38 2GENTAMICIN SULFATE; PREDNISOLONE ACETATE
39 5HYDROCORTISONE
40 2HYDROXYPROGESTERONE CAPROATE
41 1IDOXURIDINE
42 1KETOROLAC TROMETHAMINE
43 1Ketorolac Tromethamine
44 1Ketorolac tromethamine
45 2LEVOBUNOLOL HYDROCHLORIDE
46 6LIOTRIX (T4;T3)
47 3Levobunolol
48 2Levobunolol hydrochloride
49 2Linaclotide
50 1MEDRYSONE
51 1MEMANTINE HYDROCHLORIDE
52 12MORPHINE SULFATE
53 1NAPHAZOLINE HYDROCHLORIDE
54 4NEBIVOLOL HYDROCHLORIDE
55 1NEDOCROMIL SODIUM
56 1NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
57 1OFLOXACIN
58 2OXYBUTYNIN
59 2Ofloxacin
60 5OnabotulinumtoxinA
61 1PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE
62 1PODOFILOX
63 1POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
64 2PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
65 1PROPARACAINE HYDROCHLORIDE
66 2Pilocarpine
67 1Progesterone
68 1SELENIUM SULFIDE
69 3SULFACETAMIDE SODIUM
70 3Several substances refer to content
71 5TAZAROTENE
72 2TRETINOIN
73 1TRIAMCINOLONE ACETONIDE
74 3TRIMEPRAZINE TARTRATE
75 2TROSPIUM CHLORIDE
76 2Tazarotene
77 6Timolol
78 2Timolol; Bimatoprost
79 1Timolol; Brimonidine
80 2URSODIOL
81 3bimatoprost
82 1brimonidine tartrate
83 2carmellose
84 1dexametason
85 1epinastine hydrochloride
86 1pirenoxine
01 102ALLERGAN
02 14ALLERGAN HERBERT
03 3ALLERGAN INC
04 1ALLERGAN PHARMACEUT.INTERN.LTD
05 8ALLERGAN PHARMACEUTIC.IRELAND
06 14ALLERGAN SpA
07 5Allergan Pharmaceuticals (Pty) Ltd
08 12Allergan Pharmaceuticals Ireland
09 2Allergan Solvay International Limited
10 2Allergan Solvay International Ltd. (1)
11 15Allergan Solvay Ireland Ltd
12 3Allergan, Inc. Waco
01 2AEROSOL;TOPICAL
02 1Bimatoprost 0,3Mg/Ml 0.4 Ml 30Units Solution Ophthalmic Use
03 1Bimatoprost 0,3Mg/Ml 3Ml Solution Ophthalmic Use
04 1Bimatoprost 0.1Mg/Ml 3Ml Solution Ophthalmic Use
05 1Bismuth Oxide+Metronidazole+Tetracycline Hydrochloride 140+125+125Mg 120 Unita' Oral Use
06 1Brimonidine 0.2% 5Ml Solution Ophthalmic Use
07 2CAPSULE
08 21CAPSULE, EXTENDED RELEASE;ORAL
09 3CAPSULE;ORAL
10 7CREAM;TOPICAL
11 1CREAM;VAGINAL
12 2Capsule, hard
13 1Dexamethasone 700Mcg 1 Units Use Intravitreale
14 1EMULSION; OPHTHALMIC
15 6EYE DROPS, SOLUTION
16 4EYE DROPS, SOLUTION IN SINGLE-DOSE CONTAINERS
17 14Eye drops, resolution
18 1FILM, EXTENDED RELEASE;TRANSDERMAL
19 2GEL
20 1GEL, METERED;TRANSDERMAL
21 5GEL;TOPICAL
22 3INJECTABLE;INJECTION
23 1INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
24 1INTRAVITREALT IMPLANTAT I APPLIKATOR
25 1Injection fluid, resolution
26 1Intrauterine Posts
27 1Intravitrealt implant in applicator
28 1LOTION/SHAMPOO;TOPICAL
29 1Levobunolol 0.5% 0.4 Ml 60 Units Solution Ophthalmic Use
30 1Levobunolol 0.5% 5Ml Solution Ophthalmic Use
31 6OINTMENT;OPHTHALMIC
32 2OINTMENT;TOPICAL
33 3OPD
34 3POWDER FOR SOLUTION FOR INJECTION
35 1PULVER TILL INJEKTIONSVÄTSKA, LÖSNING
36 21SOLUTION/DROPS;OPHTHALMIC
37 1SOLUTION;ORAL
38 2SOLUTION;TOPICAL
39 3SUSPENSION/DROPS;OPHTHALMIC
40 2SUSPENSION;OPHTHALMIC
41 1SYRUP;ORAL
42 1TABLET (EXTENDED-RELEASE)
43 17TABLET;ORAL
44 2TABLET;ORAL-21
45 2TABLET;ORAL-28
46 3TABLET;SUBLINGUAL
47 1Timolol+Bimatoprost 300Mcg/Ml+5Mg/Ml 30 Joined' Solution Ophthalmic Use
48 1Timolol+Bimatoprost 900Mcg+15Mg Solution Ophthalmic Use
49 1Timolol+Bromonidine 0.2%+0.5% 5Ml Solution Ophthalmic Use
50 5VIAL; SINGLE-USE
51 14Blank
01 2-
02 20.01%
03 10.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
04 10.0125MG;0.0031MG
05 30.025%
06 10.025MG;0.0063MG
07 10.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
08 20.035MG;0.5MG
09 20.035MG;1MG
10 10.0375%
11 30.05%
12 10.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
13 10.05MG;0.0125MG
14 10.075%
15 10.1 MG / ML
16 20.1 mg/ml
17 60.1%
18 10.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
19 10.1%;10%
20 10.12%;0.1%
21 10.15MG;0.0375MG
22 10.1MG;0.025MG
23 10.2% (2 MG / ML)
24 10.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
25 20.2%;10%
26 10.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
27 10.25MG;0.0625MG
28 20.3 MG / ML
29 20.3 MG / ML + 5
30 40.3 mg/ml
31 40.3 mg/ml/5 mg/ml
32 20.3%
33 10.5 MG / ML
34 60.5%
35 10.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
36 51%
37 11%;0.5%
38 110 mg/ml
39 210%
40 110,000 UNITS/ML;EQ 1MG BASE/ML
41 1100 ALLERGAN
42 2100 UNITS/VIAL
43 1100MG
44 210MG
45 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
46 110MG;14MG
47 110MG;21MG
48 110MG;28MG
49 110MG;7MG
50 1120 cps 140 mg + 125 mg + 125 mg
51 1120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
52 1125MG
53 1125MG/ML
54 1130MG
55 1150MG
56 1180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
57 11mg/g
58 12 MG / ML + 5 MG / ML
59 22 mg/ml
60 22 mg/ml/5 mg/ml
61 12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
62 22.5%
63 120 mcg/24 hours
64 1200 ALLERGAN
65 1200 UNITS/VIAL
66 1200MG
67 120MG
68 220MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
69 1240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
70 1250MG
71 1250MG/ML
72 125MG
73 2290 mcg
74 12MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
75 13%
76 13.9MG/24HR
77 130%
78 130MG
79 2325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
80 1325MG;50MG;40MG;30MG
81 14
82 14% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
83 140 Monod Coll 0.4 Ml 0.03%
84 1400MG
85 140MG
86 150 ALLERGAN UNITS
87 250 UNITS/VIAL
88 1500MG
89 150MG
90 45mg/ml
91 160MG
92 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
93 1700 MIKROGRAM
94 1700 mcg
95 170MG
96 180MG
97 18MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
98 1Coll 10 Ml 0.3%
99 1Coll 10 Ml 0.5%
100 2Coll 10 Ml 1%
101 1Coll 10 Ml 2%
102 1Coll 3 Ml 0.2%
103 1Coll 3 Ml 1%
104 1Coll 5 Ml 0,5 Mg/Ml
105 1Coll 5 Ml 0.1%
106 1Coll 5 Ml 0.5%
107 1Coll Bottle Groun 0.005% + Plug Solv 7 Ml
108 1EQ 0.3% BASE
109 1EQ 0.3% BASE;0.6%
110 1EQ 0.3% BASE;1%
111 1EQ 0.35% BASE;10,000 UNITS/ML;0.5%
112 1EQ 100MG IRON/2ML (EQ 50MG IRON/ML)
113 2EQ 10MG BASE
114 3EQ 2.5MG BASE
115 1EQ 2.5MG BASE/5ML
116 1EQ 20MG BASE
117 3EQ 5MG BASE
118 1EYE DROPS 3 ML 300 mcg/ml + 5 mg/ml
119 1EYE DROPS 3 ml 0,3 mg/ml
120 1EYE DROPS 3 ml 0. 1 mg/ml
121 1EYE DROPS 5 ml 0.2% + 0.5%
122 1EYE DROPS 5 ml 2 mg/ml
123 1EYE DROPS 5 ml 5 mg/ml
124 1Pom Oftalm 3,5 G 0,3%
125 1Ung Oftalm 3 G 0,2%
126 1collyrium 30 monodose containers 0.4 ml 300 mcg/ml + 5 mg/ml
127 1collyrium 30 monodose vials 0.4 ml 0,3 mg/ml
128 1collyrium 60 monodose vials 0.4 ml 5 mg/ml
129 1intravitreale implant 700 mcg + applicator
01 3Canada
02 25Italy
03 19Norway
04 5South Africa
05 15Sweden
06 114USA
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : SORIATANE
Dosage Strength : 25MG
Packaging : 30
Approval Date :
Application Number : 2070863
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : SORIATANE
Dosage Strength : 10MG
Packaging : 30
Approval Date :
Application Number : 2070847
Regulatory Info :
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2009-08-13
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2009-08-13
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 2.5MG BASE
Packaging :
Approval Date : 2015-03-12
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Fede...
Packaging :
Approval Date : 1986-04-16
Application Number : 17534
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : CAPSULE;ORAL
Brand Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Fede...
Packaging :
Approval Date : 1986-04-16
Application Number : 17534
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Brand Name : FIORINAL W/CODEINE
Dosage Strength : 325MG;50MG;40MG;30MG
Packaging :
Approval Date : 1990-10-26
Application Number : 19429
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Dosage Form :
Brand Name : Atropine Lux
Dosage Strength : Coll 10 Ml 0.5% ...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form :
Brand Name : Atropine Lux
Dosage Strength : Coll 10 Ml 1% ...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
LOOKING FOR A SUPPLIER?